Percutaneous vertebroplasty with polymethylmethacrylate bone cement for treating elderly recurrent osteoporotic vertebral compression fractures: a report of 1-year functional follow-up

doi:10.3969/j.issn.2095-4344.2016.12.001

Abstract

Abstract:

BACKGROUND: How to effectively treat recurrent osteoporotic vertebral compression fractures in the elderly over 65 years has become an issue of attention in the clinic.
OBJECTIVE: To evaluate the clinical efficacy of percutaneous vertebroplasty with polymethylmethacrylate bone cement for treating elderly recurrent osteoporotic vertebral compression fractures.
METHODS: Twenty-four patients with elderly osteoporotic vertebral compression fractures were divided into polymethylmethacrylate bone cement group (minimally invasive group) and conservative treatment group on a voluntary basis (n=12 per group). Visual analog scale score for low back pain, Oswesty dysfunction index, ratio of the anterior/posterior margin height of the injured vertebra, Cobb angle and adverse reactions were compared between the two groups before and after treatment.
RESULTS AND CONCLUSION: The 12-month follow-up was completed in all the patients. There was one case of bone cement breakage during treatment in the minimally invasive group and one case of lower limb deep venous thrombosis in the conservative treatment group at 1 month after treatment. Compared with the conservative treatment group, the visual analog scale score, Oswesty dysfunction index, and Cobb angle were significantly lower, but the ratio of the anterior/posterior margin height of the injured vertebra was significantly higher in the minimally invasive group at 3 days, 1, 3, 6 and 12 months after treatment (P < 0.05). These findings indicate that percutaneous vertebroplasty with polymethylmethacrylate bone cement for elderly recurrent osteoporotic vertebral fractures can strive for short-term pain relief and long-term recovery of the vertebral height and spinal Cobb angle, thereby significantly improving patient’s quality of life.

中国组织工程研究杂志出版内容重点：生物材料；骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性；组织工程

Huo Zhi-ming, Guang Hong-gang, Cao Zheng-lin, Liang Liang-ke. Percutaneous vertebroplasty with polymethylmethacrylate bone cement for treating elderly recurrent osteoporotic vertebral compression fractures: a report of 1-year functional follow-up[J]. Chinese Journal of Tissue Engineering Research, 2016, 20(12): 1677-1683.

Figures/Tables 6

References

[1] Matsumoto T,Takano T,Saito H,et al.Vitamin D analogs and bone: preclinical and clinical studies with eldecalcitol. Bonekey Rep.2014;3:513.

[2] Maricic M.Use of DXA-based technology for detection and assessment of risk of vertebral fracture in rheumatology practice.Curr Rheumatol Rep. 2014; 16(8):436.

[3] Zhou Z,Chen C,Zhang J,et al.Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysise.Int J Clin Exp Pathol. 2014;7(5):2113-2122.

[4] Huang Z,Wan S,Ning L,et al.Is unilateral kyphoplasty as effective and safe as bilateral kyphoplasties for osteoporotic vertebral compression fractures? A meta-analysis.Clin Orthop Relat Res. 2014;472(9): 2833-2842.

[5] Zaryanov AV,Park DK,Khalil JG,et al.Cement augmentation in vertebral burst fractures.Neurosurg Focus.2014;37(1):E5.

[6] Feurer E,Chapurlat R.Emerging drugs for osteoporosis. Expert Opin Emerg Drugs. 2014;19(3):385-395.

[7] Chen H,Kubo KY.Bone three-dimensional microstructural features of the common osteoporotic fracture sites.World J Orthop.2014;5(4):486-495.

[8] Savage JW,Schroeder GD,Anderson PA. Vertebroplasty and Kyphoplasty for the Treatment of Osteoporotic Vertebral Compression Fractures.J Am Acad Orthop Surg.2014;22(10):653-664.

[9] Fujiwara S,Hamaya E,Sato M,et al. Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia).Clin Interv Aging. 2014;9:1879-1893.

[10] Tian J,Xiang L,Zhou D,et al.The clinical efficacy of vertebroplasty on osteoporotic vertebral compression fracture: A meta-analysis.Int J Surg. 2014;12(12): 1249-1253.

[11] Shi-Ming G, Wen-Juan L,Yun-Mei H,et al. Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for osteoporotic vertebral compression fracture: A metaanalysis.Indian J Orthop. 2015 ;49(4):377-387.

[12] Martín-López JE,Pavón-Gómez MJ,Romero-Tabares A,,et al.Stentoplasty effectiveness and safety for the treatment of osteoporotic vertebral fractures: A systematic review.Orthop Traumatol Surg Res. 2015; 101(5):627-632.

[13] Lorentzon M,Cummings SR.Osteoporosis: the evolution of a diagnosis.J Intern Med. 2015;277(6): 650-661.

[14] No YJ,Roohani-Esfahani SI,Zreiqat H. Nanomaterials: the next step in injectable bone cements. Nanomedicine (Lond).2014;9(11):1745-1764.

[15] Rahaman MN,Bal BS,Huang W.Review: emerging developments in the use of bioactive glasses for treating infected prosthetic joints.Mater Sci Eng C Mater Biol Appl.2014;41:224-231.

[16] Cauley JA,Chalhoub D,Kassem AM,et al.Geographic and ethnic disparities in osteoporotic fractures.Nat Rev Endocrinol.2014;10(6):338-351.

[17] Rossini M,Zanotti R,Viapiana O,et al.Bone involvement and osteoporosis in mastocytosis.Immunol Allergy Clin North Am.2014;34(2):383-396.

[18] Nuti R,Caffarelli C,Guglielmi G,et al.Undiagnosed vertebral fractures influence quality of life in postmenopausal women with reduced ultrasound parameters.Clin Orthop Relat Res. 2014;472(7): 2254-2261.

[19] Sone T,Ito M,Fukunaga M,et al.The effects of once-weekly teriparatide on hip geometry assessed by hip structural analysis in postmenopausal osteoporotic women with high fracture risk.Bone.2014;64:75-81.

[20] Papanastassiou ID,Filis A,Gerochristou MA, et al. Controversial issues in kyphoplasty and vertebroplasty in osteoporotic vertebral fractures.Biomed Res Int. 2014; 2014:934206.

[21] Kammerlander C,Zegg M,Schmid R,et al.Fragility fractures requiring special consideration: vertebral fractures.Clin Geriatr Med.2014;30(2):361-372.

[22] Castro-Mateos I,Pozo JM,Cootes TF,et al.Statistical shape and appearance models in osteoporosis.Curr Osteoporos Rep.2014;12(2):163-173.

[23] Qu B,Ma Y,Yan M,et al.The economic burden of fracture patients with osteoporosis in western China.Osteoporos Int.2014;25(7):1853-1860.

[24] Ensrud KE,Taylor BC,Peters KW,et al.Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study. BMJ.2014;349:g4120.

[25] Zhang YZ,Kong LD,Cao JM,et al.Incidence of subsequent vertebral body fractures after vertebroplasty.J Clin Neurosci.2014;21(8):1292-1297.

[26] Kroon F,Staples M,Ebeling PR,et al.Two-year results of a randomized placebo-controlled trial of vertebroplasty for acute osteoporotic vertebral fractures.J Bone Miner Res.2014;29(6):1346-1355.

[27] Zhou Z,Chen C,Zhang J,et al.Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis.Int J Clin Exp Pathol. 2014;7(5):2113-2122.

[28] Gerdhem P.Osteoporosis and fragility fractures: Vertebral fractures.Best Pract Res Clin Rheumatol. 2013;27(6):743-755.

[29] Misra D,Zhang Y,Peloquin C,et al.Incident long-term warfarin use and risk of osteoporotic fractures: propensity-score matched cohort of elders with new onset atrial fibrillation.Osteoporos Int. 2014;25(6): 1677-1684.

[30] Olsen CF,Bergland A.The effect of exercise and education on fear of falling in elderly women with osteoporosis and a history of vertebral fracture: results of a randomized controlled trial.Osteoporos Int. 2014; 25(8):2017-2025.

[31] van Griensven M,Biberthaler P.Therapy of osteoporotic fractures - new therapeutic options.MMW Fortschr Med. 2014;156(18):48-50.

[32] Savage JW,Schroeder GD,Anderson PA.Vertebroplasty and Kyphoplasty for the Treatment of Osteoporotic Vertebral Compression Fractures.J Am Acad Orthop Surg. 2014;22(10):653-664.

[33] Kim HJ,Yi JM,Cho HG,et al.Comparative study of the treatment outcomes of osteoporotic compression fractures without neurologic injury using a rigid brace, a soft brace, and no brace: a prospective randomized controlled non-inferiority trial.J Bone Joint Surg Am. 2014;96(23):1959-1966.

[34] Benoist M.The Michel Benoist and Robert Mulholland yearly European Spine Journal Review: a survey of the "medical" articles in the European Spine Journal, 2014. Eur Spine J.2015;24(1):12-21.

[35] Yang H,Pan J,Wang G.A review of osteoporotic vertebral fracture nonunion management.Spine (Phila Pa 1976). 2014;39(26 Spec No.):B4-6.

[36] Brincat M,Gambin J,Brincat M,et al.The role of vitamin D in osteoporosis.Maturitas.2015;80(3):329-332.

[37] Lorentzon M,Cummings SR.Osteoporosis: the evolution of a diagnosis.J Intern Med. 2015;277(6): 650-661.

[38] Griffith JF. Identifying osteoporotic vertebral fracture.Quant Imaging Med Surg. 2015;5(4):592-602.

[39] Lems WF,Geusens P.Established and forthcoming drugs for the treatment of osteoporosis.Curr Opin Rheumatol. 2014;26(3):245-251

[40] Giangregorio LM,MacIntyre NJ,Heinonen A,et al.Too Fit To Fracture: a consensus on future research priorities in osteoporosis and exercise.Osteoporos Int.2014;25(5):1465-1472.